Its pharmacological doses improve metabolicparameters in animals and people with obesity: theyincreaseenergy expenditure and insulin sensitivity and reduceblood glucose levels (Kharitonenkov et al., 2005; Coskun etal., 2008). The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.